PharmaCord
PharmaCord is a US-based specialty pharmaceutical patient services and hub services provider that partners with pharmaceutical manufacturers to deliver technology-enabled access, affordability, adherence, and engagement support across over 100 specialty therapy products.
- Company typePrivate
- Founded2016
- HeadquartersLouisville, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What PharmaCord does
PharmaCord is a privately held US healthcare services company headquartered in Jeffersonville, Indiana, founded in 2016. The company delivers specialty pharmaceutical patient support services and hub services to pharmaceutical manufacturers, addressing patient access, affordability, adherence, and engagement requirements for specialty medications. Its technology-enabled platform coordinates end-to-end commercialization workflows and currently supports over 100 pharmaceutical products across the United States.
The company's customer base is concentrated in the pharmaceutical manufacturing vertical, where it functions as a service-provider partner helping manufacturers reach and support patients on complex specialty therapies. PharmaCord's operating model is structured around long-term service contracts with manufacturers, though specific pricing models and revenue mechanics are not publicly disclosed. Its core technology stack centers on a proprietary specialty pharmaceutical patient services and hub services platform, with stated expansion capabilities intended to broaden the technology footprint. In June 2024, PharmaCord received a substantial investment from Permira, a global private equity firm, to fund growth, expand its technological offerings, and accelerate its position in the specialty pharma services sector. The company employs between 1,001 and 5,000 people and currently operates a US-only footprint.
PharmaCord firmographics
Firmographics- Name
- PharmaCord
- Legal name
- PharmaCord
- Website
- https://pharmacord.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- PharmaCord is a US-based specialty pharmaceutical patient services and hub services provider that partners with pharmaceutical manufacturers to deliver technology-enabled access, affordability, adherence, and engagement support across over 100 specialty therapy products.
- Ownership category
- akta.pro rank
PharmaCord industry classification
Industry- Product category
- Specialty Pharmaceutical Patient Services
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)
- akta.pro secondary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where PharmaCord is headquartered
LocationHeadquarters
- HQ city
- Louisville
- HQ country
- United States
- HQ region
- North America
Markets served
PharmaCord business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
PharmaCord product offering
Product offeringCore offering
PharmaCord is a healthcare services company that provides specialty pharmaceutical hub services supporting over 100 pharmaceutical products. The company delivers patient access, affordability, adherence, and engagement solutions that help pharmaceutical manufacturers connect patients prescribed specialty medications with the therapies, financial assistance, and ongoing support they need.
Product overview
PharmaCord is a pharma services company offering patient support services for the pharmaceutical industry, with a focus on specialty medications. The company supports over 100 pharmaceutical products through hub services that improve patient experience. Based in Jeffersonville, Indiana, PharmaCord provides end-to-end commercialization services including patient access, affordability programs, and specialty pharmacy coordination.
Differentiator
Problem solved
Functional benefit
Products and services
- Specialty Pharmaceutical Hub Services End-to-end hub services that help pharmaceutical manufacturers deliver, coordinate, and support specialty medications for patients, covering access, affordability, adherence, and engagement.
- Patient Access and Affordability Programs Services that help patients prescribed specialty medications gain access to therapies through benefits investigation, prior authorization support, copay assistance, and financial aid program coordination.
- Patient Adherence and Engagement Solutions
Companies that use PharmaCord
Customer profileSegments1 record
Ideal customer profiles1 record
PharmaCord technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PharmaCord partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Expansion highlights5 records
PharmaCord competitors and assessment
Company assessmentDirect peers
- ConnectiveRx: ConnectiveRx delivers patient access, affordability, and adherence solutions combined with pharmacy network services, competing with PharmaCord for specialty pharmaceutical manufacturer contracts.
- CareMetx: CareMetx delivers hub services, patient support, and specialty pharmacy coordination for specialty drug manufacturers, directly competing with PharmaCord for manufacturer contracts across access and adherence programs.
- EVERSANA: EVERSANA is an integrated commercial services provider offering patient access, hub services, adherence, and affordability solutions for life sciences manufacturers—overlapping substantially with PharmaCord's end-to-end commercialization offering.
- Triplefin: Triplefin provides hub services, patient assistance programs, copay support, and pharmacy network solutions for pharma and consumer health manufacturers—a direct competitor to PharmaCord.
- Lash Group (AmerisourceBergen/Cencora): Lash Group is a leading patient access and hub services provider serving specialty pharmaceutical manufacturers with reimbursement, copay, adherence, and case management support—the most direct competitor to PharmaCord's core offering.
- Sonexus Health: Sonexus Health provides patient access, affordability, and adherence services for specialty medications on behalf of pharma manufacturers, mirroring PharmaCord's hub services model and serving the same client base.
- Ashfield Engage (Inizio): Ashfield Engage, part of Inizio, delivers patient engagement, nurse support, and access services for pharma manufacturers, competing directly with PharmaCord's patient services and adherence offerings.
Broad incumbents
- Syneos Health: Syneos Health provides commercial and patient engagement solutions to biopharma, including patient services, market access, and consulting capabilities that intersect with PharmaCord's access and adherence offerings.
- McKesson (US Bioservices / Biologics by McKesson): McKesson operates specialty pharmacies and patient services offerings through US Bioservices that compete with PharmaCord's hub services and specialty pharmacy coordination capabilities, leveraging its broader distribution scale.
- Cardinal Health (Sonexus / Specialty Networks): Cardinal Health is a major specialty pharma distributor with patient services and hub offerings that overlap with PharmaCord's services for pharmaceutical manufacturers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
PharmaCord social profiles
Digital presencePharmaCord financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaCord leadership team
Management profileNumber of profiles
Profiles9 records
PharmaCord funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaCord M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaCord
What does PharmaCord do?
PharmaCord is a healthcare services company that provides specialty pharmaceutical hub services supporting over 100 pharmaceutical products. The company delivers patient access, affordability, adherence, and engagement solutions that help pharmaceutical manufacturers connect patients prescribed specialty medications with the therapies, financial assistance, and ongoing support they need.
Is PharmaCord a public or private company?
PharmaCord is a private company. It is classified as private equity controlled and is currently operating.
When was PharmaCord founded?
PharmaCord was founded in 2016. It employs 1,001 to 5,000 people.
Where is PharmaCord based?
PharmaCord is headquartered in Louisville, United States, in the North America region.
Who are PharmaCord's main competitors?
Direct peers on record are ConnectiveRx, CareMetx, EVERSANA, Triplefin, Lash Group (AmerisourceBergen/Cencora), Sonexus Health and Ashfield Engage (Inizio). Broad incumbents are Syneos Health, McKesson (US Bioservices / Biologics by McKesson) and Cardinal Health (Sonexus / Specialty Networks).
Does PharmaCord have an API?
No public API is recorded for PharmaCord.
What industry is PharmaCord in?
PharmaCord's product category is Specialty Pharmaceutical Patient Services. Its primary akta.pro industry code is HLAIAKAG, Patient Access Programs & Affordability (Copay/Hubs/PSP), with a secondary code of HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 524292 and its SIC code is 8000.